(MGTX), Wednesday announced that the U.S. Food and Drug Administration has granted the Rare Pediatric Disease Designation to its AAV8-RK-RetGC program for the treatment of patients with Leber ...

MeiraGTx receives FDA Rare Pediatric Disease Designation for AAV8-RK-RetGC to treat Leber congenital amaurosis due to GUCY2D mutations. MeiraGTx Holdings Plc announced that the FDA has granted its ...

Explore a data page featuring stocks with significant promoter ownership, indicating strong control, stability, and alignment of interests for investors ...

the development of a recombinant baculovirus vector accommodating the engineered GFAP promoter was shown to drive astrocyte-specific expression in cultured cells. This approach reduced possible side ...

Its key shareholders are four public sector undertakings - NTPC, Power Grid Corporation of India, PFC and NHPC - all of which are promoters of the company. They want to relinquish that role to ...

The decline followed Thursday evening's announcement that its promoter proposes to divest up to 20% stake in the company through an Offer For Sale (OFS). "Adani Commodities LLP is one of the ...

The current human tissue-based study provides convincing evidence correlating hippocampal expressions of RNA guanine-rich G-quadruplexes with aging and with Alzheimer's Disease presence and severity.

Photo: Brendan Bradford Goodman re-injured his eye on Saturday morning with No Limit Promoter Matt Rose sharing his devastation for the Aussie boxer. “It’s just devastating,” Rose said to ...